Gemcitabine plus vinorelbine chemotherapy in patients with advanced bladder carcinoma who are medically unsuitable for or who have failed cisplatin-based chemotherapy.

Turkolmez K., Beduk Y., Baltaci S., Gogus Ç. M., Gogus O.

European urology, cilt.44, sa.6, ss.682-6, 2003 (SCI-Expanded) identifier identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 44 Sayı: 6
  • Basım Tarihi: 2003
  • Doi Numarası: 10.1016/s0302-2838(03)00385-3
  • Dergi Adı: European urology
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.682-6
  • Anahtar Kelimeler: gemcitabine, vinorelbine, bladder tumor, chemotherapy, TRANSITIONAL-CELL-CARCINOMA, PHASE-II TRIAL, METASTATIC UROTHELIAL CANCER, COOPERATIVE-ONCOLOGY-GROUP, URINARY-TRACT, BREAST-CANCER, METHOTREXATE, VINBLASTINE, COMBINATION, IFOSFAMIDE
  • Ankara Üniversitesi Adresli: Evet

Özet

Objective: To evaluate the efficacy and toxicity of gemcitabine plus vinorelbine chemotherapy in patients with advanced bladder carcinoma who are unsuitable for or who have failed cisplatin-containing chemotherapy.